Yingduo Yu

机构：National Clinical Research Center for Digestive Diseases, First Affiliated Hospital Zhejiang University, Zhejiang University

发表论文 10 篇 · 总被引 149 次 · h-index 5

代表论文

• MSC-derived exosomes attenuate hepatic fibrosis in primary sclerosing cholangitis through inhibition of Th17 differentiation (2024 · Asian Journal of Pharmaceutical Sciences · 被引 36)
• Mesenchymal stem cells shift the pro-inflammatory phenotype of neutrophils to ameliorate acute lung injury (2023 · Stem Cell Research & Therapy · 被引 36)
• Human Placental Mesenchymal Stem Cells Relieve Primary Sclerosing Cholangitis via Upregulation of TGR5 in Mdr2 −/− Mice and Human Intrahepatic Cholangiocyte Organoid Models (2023 · Research · 被引 28)
• ROS-responsive nanoparticle delivery of obeticholic acid mitigate primary sclerosing cholangitis (2024 · Journal of Controlled Release · 被引 22)
• Co-delivery of azithromycin and ibuprofen by ROS-responsive polymer nanoparticles synergistically attenuates the acute lung injury (2023 · Biomaterials Advances · 被引 17)
• Serum metabonomics reveal the effectiveness of human placental mesenchymal stem cell therapy for primary sclerosing cholangitis (2024 · Stem Cell Research & Therapy · 被引 4)